N-Nitroso Edoxaban Desmethyl Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs . N-Nitroso Edoxaban Desmethyl Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Desmethyl Impurity chemically represented as N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5- nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2- carboxamido)cyclohexyl)oxalamid .Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Desmethyl Impurity. We supply N-Nitroso Edoxaban Desmethyl Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014388 |
| CAS No | NA |
| Mol.F. | C10H15N3O3S |
| Mol.Wt. | 257.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014389 |
| CAS No | NA |
| Mol.F. | C14H18N6O3 |
| Mol.Wt. | 318.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014390 |
| CAS No | NA |
| Mol.F. | C16H19N3O6S |
| Mol.Wt. | 381.40 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014391 |
| CAS No | NA |
| Mol.F. | C11H14N4O2 |
| Mol.Wt. | 234.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014392 |
| CAS No | NA |
| Mol.F. | C14H19N3O2 |
| Mol.Wt. | 261.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014393 |
| CAS No | 1184873-13-9 |
| Mol.F. | C18H21N3O |
| Mol.Wt. | 295.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014394 |
| CAS No | 1184873-14-0 |
| Mol.F. | C19H23N3O |
| Mol.Wt. | 309.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014395 |
| CAS No | NA |
| Mol.F. | C19H19N9O6 |
| Mol.Wt. | 469.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014396 |
| CAS No | NA |
| Mol.F. | C13H15N3O6 |
| Mol.Wt. | 309.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014397 |
| CAS No | NA |
| Mol.F. | C14H18N4O6 |
| Mol.Wt. | 338.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014398 |
| CAS No | 88381-44-6 |
| Mol.F. | C4H6N2O3S |
| Mol.Wt. | 162.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014399 |
| CAS No | 6238-69-3 |
| Mol.F. | C6H10N2O3 |
| Mol.Wt. | 158.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014400 |
| CAS No | NA |
| Mol.F. | C22H30N2O7S |
| Mol.Wt. | 466.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014401 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O |
| Mol.Wt. | 315.80 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014402 |
| CAS No | NA |
| Mol.F. | C13H18N4O2 |
| Mol.Wt. | 262.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014403 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O |
| Mol.Wt. | 320.8 g/mol |
| INV STATUS | In Stock |